Study Finds Calcium Dobesilate Fails to Reduce Incidence of Macular Edema

May 3, 2009

As recently reported on MedPage Today, Christos Haritoglou, M.D., of Ludwig-Maximilians-University in Munich, Germany, and fellow researchers reported in the April 2009 issue of The Lancet, that in a randomized, placebo-controlled trial, calcium dobesilate failed to lower the incidence of clinically significant macular edema. Specifically, over five years of follow-up, the probability of macular edema was 35% in the treatment arm, not significantly different from the 28% seen in the placebo arm.

While the researchers were disappointed by the result, they noted the importance of rejecting the utility of a drug already on the market and thereby stop the costly use of a pharmaceutical that may have limited or no benefit to the patient.

Read the full story on MedPage Today.




Jump down to form below to submit your own comments

Comments are closed.